ArticleJournal of the Society for Cardiovascular Angiography & Interventions2026
Pulmonary Embolism in the United States: A Report From the National PERT Consortium.
Article in Journal of the Society for Cardiovascular Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Trends and Therapeutic Imperatives in Pulmonary Embolism Therapy.Journal of the Society for Cardiovascular Angiography & Interventions · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pulmonary embolism (PE) remains the third leading cause of cardiovascular-related mortality, and few efforts have been made to study it exclusively through real-world registry data. This research shows demographic and outcomes data from a real-world, PE-specific database, yielding a contemporary examination of PE care in the United States. Methods: All data were extracted from the National PERT Consortium registry. This study included consecutive patients diagnosed with PE from October 2015 to June 2024 at 54 US sites. All patients were assigned a PE-specific risk stratification score based on available data. Descriptive statistics were used to analyze the data. Results: During the study period, 11,612 unique patients were included for analysis, with the majority (73.7%) classified as intermediate risk. Patients tended to be slightly obese (mean body mass index, 31.1 kg/m Conclusion: Real-world data from the National PERT Consortium database demonstrate current practices in the care of patients with PE. Opportunities exist for better risk stratification and improvement in care across the spectrum of PE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.